alexion pharmaceuticals inc
(ALXN:Consolidated Issue Listed on NASDAQ Global Select )
Chief Strategy & Portfolio Officer and Senior Vice President, Alexion Pharmaceuticals, Inc.
|Age||Total Calculated Compensation||This person is connected to 0 board members in 0 different organizations across 2 different industries.|
Mr. Saqib Islam has been the Chief Strategy & Portfolio Officer and Senior Vice President of Alexion Pharmaceuticals, Inc. since April 2013. Mr. Islam served as a Managing Director of Morgan Stanley since December 2005. He has 18 years of experience in global business management, with a focus on business development, strategic decision-making and planning, and capital markets. He focus on both executing corporate growth strategies as well as contributing to assessment ...
352 Knotter DrivePhone: 203-272-2596
Cheshire, Connecticut 06410
Board Members Memberships*There is no Board Members Memberships data available.
School Of Law, Columbia University
Annual Compensation*There is no Annual Compensation data available.
Stock Options*There is no Stock Options data available.
Total Compensation*There is no Total Compensation data available.
|Leonard S. Schleifer M.D., Ph.D.||Co-Founder, Chief Executive Officer, President, Executive Director and Ex Officio Member of Technology Committee|
Regeneron Pharmaceuticals, Inc.
|Martine A. Rothblatt Ph.D., J.D., MBA||Founder, Chairman and Chief Executive Officer|
United Therapeutics Corporation
|Jeffrey M. Leiden M.D., Ph.D.||Chairman, Chief Executive Officer and President|
Vertex Pharmaceuticals Incorporated
|Simon E. Moroney Ph.D.||Chairman of Management Board and Chief Executive Officer|
|Randal J. Kirk J.D.||Chairman, Chief Executive Officer and President|
|--||Compensation as of Fiscal Year 2012.|